Physostigmine Salicylate (Akorn)


Welcome to the PulseAid listing for the Physostigmine Salicylate drug offered from Akorn. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn
NON-PROPRIETARY NAME: Physostigmine Salicylate
SUBSTANCE NAME: PHYSOSTIGMINE SALICYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2010-08-10
END MARKETING DATE: 0000-00-00


Physostigmine Salicylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPhysostigmine Salicylate from Akorn
LABELER NAME: Akorn
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2010-08-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-510_11695f58-c5a9-424d-954d-086275b40291
PRODUCT NDC: 17478-510
APPLICATION NUMBER:

Other PHYSOSTIGMINE SALICYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AkornPhysostigmine Salicylate
Cardinal HealthPhysostigmine Salicylate